Literature DB >> 26694635

Cdc6: Skin in the carcinogenesis game.

Leonardo K Teixeira1, Steven I Reed2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26694635      PMCID: PMC4943738          DOI: 10.1080/15384101.2015.1131528

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication.

Authors:  Arkaitz Ibarra; Etienne Schwob; Juan Méndez
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

2.  Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.

Authors:  Susana Gonzalez; Peter Klatt; Sonia Delgado; Esther Conde; Fernando Lopez-Rios; Montserrat Sanchez-Cespedes; Juan Mendez; Francisco Antequera; Manuel Serrano
Journal:  Nature       Date:  2006-03-30       Impact factor: 49.962

3.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

4.  Deregulated expression of Cdc6 in the skin facilitates papilloma formation and affects the hair growth cycle.

Authors:  Sabela Búa; Peggy Sotiropoulou; Cecilia Sgarlata; Luis R Borlado; Manuel Eguren; Orlando Domínguez; Sagrario Ortega; Marcos Malumbres; Cedric Blanpain; Juan Méndez
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.

Authors:  Jirina Bartkova; Nousin Rezaei; Michalis Liontos; Panagiotis Karakaidos; Dimitris Kletsas; Natalia Issaeva; Leandros-Vassilios F Vassiliou; Evangelos Kolettas; Katerina Niforou; Vassilis C Zoumpourlis; Munenori Takaoka; Hiroshi Nakagawa; Frederic Tort; Kasper Fugger; Fredrik Johansson; Maxwell Sehested; Claus L Andersen; Lars Dyrskjot; Torben Ørntoft; Jiri Lukas; Christos Kittas; Thomas Helleday; Thanos D Halazonetis; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Nature       Date:  2006-11-30       Impact factor: 49.962

6.  Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress.

Authors:  Xin Quan Ge; Dean A Jackson; J Julian Blow
Journal:  Genes Dev       Date:  2007-12-15       Impact factor: 11.361

7.  Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior.

Authors:  Michalis Liontos; Marilena Koutsami; Maria Sideridou; Konstantinos Evangelou; Dimitris Kletsas; Brynn Levy; Athanassios Kotsinas; Odelia Nahum; Vassilis Zoumpourlis; Mirsini Kouloukoussa; Zoi Lygerou; Stavros Taraviras; Christos Kittas; Jirina Bartkova; Athanasios G Papavassiliou; Jiri Bartek; Thanos D Halazonetis; Vassilis G Gorgoulis
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

  7 in total
  4 in total

1.  CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.

Authors:  H Zhao; X Zhou; G Yuan; Z Hou; H Sun; N Zhai; B Huang; X Li
Journal:  Clin Transl Oncol       Date:  2020-07-13       Impact factor: 3.405

2.  LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis.

Authors:  Juze Yang; Xinyi Qian; Qiongzi Qiu; Lingling Xu; Meidie Pan; Jia Li; Jiayi Ren; Bingjian Lu; Ting Qiu; Enguo Chen; Kejing Ying; Honghe Zhang; Yan Lu; Pengyuan Liu
Journal:  Cell Death Dis       Date:  2022-10-18       Impact factor: 9.685

3.  Identification of a seven-cell cycle signature predicting overall survival for gastric cancer.

Authors:  Lian-Qun Zhang; Sheng-Li Zhou; Jun-Kuo Li; Pei-Nan Chen; Xue-Ke Zhao; Li-Dong Wang; Xiu-Ling Li; Fu-You Zhou
Journal:  Aging (Albany NY)       Date:  2022-05-10       Impact factor: 5.955

4.  WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck.

Authors:  Vassiliki Saloura; Theodore Vougiouklakis; Makda Zewde; Kazuma Kiyotani; Jae-Hyun Park; Guimin Gao; Theodore Karrison; Mark Lingen; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Oncotarget       Date:  2016-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.